Septerna (SEPN) Cash from Operations (2023 - 2026)
Septerna's (SEPN) quarterly Cash from Operations came in at 25633000.0 in Q1 2026, down 9.81% year-on-year from 28421180.78 in Q1 2025, and down 71.02% quarter-over-quarter from 14988000.0 in Q4 2025.
Septerna (SEPN) Cash from Operations (2023 - 2026) Analysis & Trends
Septerna's Cash from Operations history runs 4 years deep, the most recent figure standing at 25633000.0 for Q1 2026.
- On a quarterly basis, Cash from Operations fell 9.81% year-over-year to 25633000.0 in Q1 2026; TTM through Mar 2026 was 107899000.0, a 245.61% increase from a year earlier, with the FY2025 full-year figure at 110189000.0, up 263.32% from the prior year.
- Cash from Operations declined to 25633000.0 in Q1 2026 per SEPN's latest filing, from 14988000.0 in the prior quarter.
- Across five years, Cash from Operations topped out at 168807000.0 in Q3 2025 and bottomed at 25633000.0 in Q1 2026.
- The 4-year median for Cash from Operations is 16762500.0 (2024), against an average of 828900.0.
- Across the five-year window, Cash from Operations sank 138.24% in 2024 and surged 1103.97% in 2025, its largest moves.
- Year by year, Cash from Operations stood at 8797000.0 in 2023, then tumbled by 138.24% to 20958000.0 in 2024, then increased by 28.49% to 14988000.0 in 2025, then sank by 71.02% to 25633000.0 in 2026.
- Per Business Quant, the three latest SEPN Cash from Operations figures stand at 25633000.0 (Q1 2026), 14988000.0 (Q4 2025), and 168807000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -19.59 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 201.34 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.53 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.43 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.08 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -354.17 Mn |
| 10 | Septerna | 1.50 Bn | 1.50 Bn | - | -25.63 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -25.63 Mn |
| Mar 31, 2026 | -25.63 Mn |
| Dec 31, 2025 | -14.99 Mn |
| Dec 31, 2025 | -14.99 Mn |
| Sep 30, 2025 | 168.81 Mn |
| Sep 30, 2025 | 168.81 Mn |
| Jun 30, 2025 | -20.29 Mn |
| Jun 30, 2025 | -20.29 Mn |
| Mar 31, 2025 | -23.34 Mn |
| Mar 31, 2025 | -23.34 Mn |
| Dec 31, 2024 | -20.96 Mn |
| Dec 31, 2024 | -20.96 Mn |
| Sep 30, 2024 | -16.81 Mn |
| Sep 30, 2024 | -16.81 Mn |
| Jun 30, 2024 | -12.99 Mn |
| Jun 30, 2024 | -12.99 Mn |
| Mar 31, 2024 | -16.71 Mn |
| Mar 31, 2024 | -16.71 Mn |
| Dec 31, 2023 | -8.80 Mn |
| Dec 31, 2023 | -8.80 Mn |